Trial Profile
Prospective study to evaluate effect of early treatment of pediatric patients of Influenza A H1N1 (pdm09) with a neuraminidase inhibitor
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary) ; Zanamivir (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Therapeutic Use
- 16 Dec 2015 Status changed from not stated to completed.
- 28 Nov 2015 New trial record